Table 1.
Visit | Sample collection (peripheral blood and intestinal tissue) |
Treatment | CRP (mg/L) |
Calprotectin (μg/g) |
PUCAI | |
---|---|---|---|---|---|---|
February 2015 | S0 | Presentation with severe acute colitis. Diagnostic endoscopy with biopsies in small intestine and colon. | No treatment | 19 | 2861 μg/g | 55 |
August 2015 | S1 | Persistent disease activity using infliximab 10 mg/kg every 4 weeks and azathioprine 25 mg/day. Received blood sample. | Infliximab 5 mg/kg/day per 4 weeks, Azathioprine 1dd30 mg, Allopurinol 1dd50 mg, Cholecalciferol 1dd800IE, Omeprazol 1dd10 mg, Cotrimoxazol 1dd30mg | <3 | ND | 45 |
December 2016 | S2 | Subtotal colectomy with ileostoma. Received blood sample and intestinal tissue of patient. | Infliximab 5 mg/kg/day per 4 weeks (last infusion on 21st of December 2015), Azathioprine 1dd30 mg, Allopurinol 1dd50 mg, Cholecalciferol 1dd800IE, Omeprazol 1dd10 mg, Vancomycin 2dd250 mg, Gentamicin 2dd50 mg | 209 | ND | 55 |
January 2017 | S3 | Closure of double-barreled ileostomy, one month protectomy and ileoanal pouch anastomosis. No symptoms of intestinal disease. Received blood samples of patient and parents. |
No immunosuppressive treatment. No recent antibiotic use. |
ND | ND | 0 |
August 2017 | S4 | Regular visit at outpatient clinic. No symptoms of intestinal disease. Received blood samples of patient and parents. |
No immunosuppressive treatment. No recent antibiotic use. |
ND | ND | 0 |
CRP C-reactive protein, PUCAI pediatric ulcerative colitis activity index, dd daily dosis, ND not determined.